Das ANGPTL8-Gen kodiert einen Inhibitor der Lipolyse. Somit ist dieses Gen ein Kandidat für Störungen im Fettstoffwechsel mit überwiegender Hypertriglyceridämie.
| Klinisch | Untersuchungsmethoden | Familienuntersuchung |
| Bearbeitungszeit | 5 Tage | |
| Probentyp | genomische DNS |
| Forschung | Untersuchungsmethoden | Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens |
| Bearbeitungszeit | 25 Tage | |
| Probentyp | genomische DNS |
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
| 1. |
Cefalù AB et al. () Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.
|
| 2. |
None (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels.
|
| 3. |
Quagliarini F et al. (2012) Atypical angiopoietin-like protein that regulates ANGPTL3.
|
| 4. |
Tseng YH et al. (2014) Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism.
|
| 5. |
Gusarova V et al. (2014) ANGPTL8/betatrophin does not control pancreatic beta cell expansion.
|
| 6. |
NCBI article NCBI 55908
|
| 7. |
OMIM.ORG article Omim 616223
|
| 8. |
Wikipedia Artikel Wikipedia DE (Betatrophin)
|